Healthcare / Medical Care FacilitiesASX
$6.97
+0.30 (+4.50%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 22% · confianza 25%
FCF escenarios
weak_data · normalized FCF $339.8M · quality 79.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
45/100
C
Piotroski
1/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$1.7B
P/E
7.7x
↓EV/EBITDA
12.2x
↓ROE
7.8%
↑Gross Margin
90.0%
↑Debt/Equity
0.59
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+15.0%
FCF CAGR
+1.2%
FCF margin
90.8%
FCF / Net income
1.26x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $360.9M · net income $259.7M · FCF $327.6M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $360.9M | $360.9M | $318.6M | $270.5M | $237.0M |
| Net Income | $259.7M | $259.7M | $339.8M | $436.3M | $269.1M |
| EBITDA | $299.1M | $299.1M | $400.7M | $465.3M | $295.1M |
| EPS | 1.08 | 1.08 | 1.44 | 1.87 | 1.16 |
| Gross Margin | 90.0% | 90.0% | 90.4% | 90.2% | 90.5% |
| Operating Margin | 1.6% | 1.6% | 4.8% | 2.5% | 4.9% |
| Net Margin | 72.0% | 72.0% | 106.7% | 161.3% | 113.6% |
| Balance Sheet | |||||
| Debt/Equity | 0.59 | 0.59 | 0.58 | 0.54 | 0.49 |
| Current Ratio | 0.13 | 0.13 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $327.6M | $327.6M | $358.3M | $339.8M | $315.6M |
| Returns | |||||
| ROE | 7.8% | 7.8% | 11.4% | 16.7% | 12.3% |
| Valuation | |||||
| P/E | 7.74 | 7.74 | 8.31 | 5.13 | 7.31 |
| EV/EBITDA | 12.21 | 12.21 | 11.32 | 7.81 | 10.23 |
| P/B | 0.50 | 0.50 | 0.95 | 0.86 | 0.90 |
| Growth & Yield | |||||
| Revenue Growth | 13.3% | 13.3% | 17.8% | 14.2% | — |
| EPS Growth | -25.2% | -25.2% | -22.9% | 60.8% | — |
| Dividend Yield | 2.7% | 2.7% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-16.9%
EPS terminal req.
$0.62
Spread vs growth
-8.3%
5Y implied EPS CAGR
-7.1%
EPS terminal req.
$0.75
Spread vs growth
-18.2%
10Y implied EPS CAGR
1.1%
EPS terminal req.
$1.21
Spread vs growth
-26.3%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-26.9%
Start / end P/E
6.9x → 6.5x
EPS bridge
1.44 → 1.08
Residual
+1.5%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.